Royalty Pharma Plc (RPRX)
69.31
+0.34
(+0.49%)
USD |
NASDAQ |
Nov 13, 16:00
69.30
0.00 (0.00%)
After-Hours: 19:59
Royalty Pharma Price to Book Value : 4.520 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.520 |
| November 12, 2026 | 4.497 |
| November 11, 2026 | 4.565 |
| November 10, 2026 | 4.529 |
| November 09, 2026 | 4.484 |
| November 06, 2026 | 4.388 |
| November 05, 2026 | 4.406 |
| November 04, 2026 | 4.406 |
| November 03, 2026 | 4.330 |
| November 02, 2026 | 4.338 |
| October 30, 2026 | 4.381 |
| October 29, 2026 | 4.299 |
| October 28, 2026 | 4.227 |
| October 27, 2026 | 4.257 |
| October 26, 2026 | 4.223 |
| October 23, 2026 | 4.164 |
| October 22, 2026 | 4.157 |
| October 21, 2026 | 4.053 |
| October 20, 2026 | 4.059 |
| October 19, 2026 | 3.930 |
| October 16, 2026 | 3.975 |
| October 15, 2026 | 3.888 |
| October 14, 2026 | 3.847 |
| October 13, 2026 | 3.689 |
| October 12, 2026 | 3.768 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.712 |
| October 08, 2026 | 3.665 |
| October 07, 2026 | 3.701 |
| October 06, 2026 | 3.680 |
| October 05, 2026 | 3.695 |
| October 02, 2026 | 3.727 |
| October 01, 2026 | 3.758 |
| September 30, 2026 | 3.806 |
| September 29, 2026 | 3.798 |
| September 28, 2026 | 3.808 |
| September 25, 2026 | 3.797 |
| September 24, 2026 | 3.803 |
| September 23, 2026 | 3.761 |
| September 22, 2026 | 3.818 |
| September 21, 2026 | 3.812 |
| September 18, 2026 | 3.810 |
| September 17, 2026 | 3.844 |
| September 16, 2026 | 3.814 |
| September 15, 2026 | 3.814 |
| September 14, 2026 | 3.852 |
| September 11, 2026 | 3.824 |
| September 10, 2026 | 3.833 |
| September 09, 2026 | 3.953 |
| September 08, 2026 | 3.953 |
| September 04, 2026 | 4.172 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.119 |
| ANI Pharmaceuticals, Inc. | 2.568 |
| Corcept Therapeutics, Inc. | 9.568 |
| Veru, Inc. | 1.256 |
| Johnson & Johnson | 8.437 |
Price to Book Value Related Metrics
| PE Ratio | 45.10 |
| PS Ratio | 13.90 |
| Price to Free Cash Flow | 28.44 |
| Price | 69.31 |
| Earnings Yield | 2.22% |
| Market Cap | 30.90B |
| Operating PE Ratio | 21.21 |
| Normalized PE Ratio | 38.69 |